At CTS, we understand the impact converting to the Ortho viral marker platform has on your operations. As we get closer to our implementation date of January 11, 2021 we are committed to providing you information as it becomes available.
Package inserts for the new assays are now available. You can review them on the Communications page by clicking this link: Communications,
On June 13, 2019, CTS provided information regarding the manufacturer’s discontinuation of HIV...
CTS originally communicated that Tampa will convert from the current Grifols Ultrio Plus NAT triplex...
A new Learning Center website will launch on Monday, March 30, 2020. While the link to the new Learn...
FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screen...
Reminder test emails for the Health and Human Services (HHS) email notifications for WNV reactives h...
Seasonal monitoring of epidemic triggers for West Nile Virus (WNV) NAT tested donations will begin J...